Accepted for Publication: September 7, 2013.
Published Online: April 2, 2014. doi:10.1001/jamadermatol.2013.8442.
Study concept and design: Sanchez, Grichnik.
Acquisition of data: Sanchez, Rabinovitz, Oliviero, Elgart, Perez, Puig, Malvehy.
Analysis and interpretation of data: Sanchez, Grichnik.
Drafting of the manuscript: Sanchez, Grichnik.
Critical revision of the manuscript for important intellectual content: All authors.
Obtained funding: Grichnik.
Administrative, technical, and material support: Sanchez, Perez, Grichnik.
Study supervision: Grichnik.
Conflict of Interest Disclosures: Dr Rabinovitz has served as a consultant to 3Gen, and Ms Oliviero has been a speaker for 3Gen. Drs Rabinovitz and Grichnik have served as consultants for and received meeting support and equipment from Caliber ID Inc. Dr Rabinovitz has also served as a consultant to MELA Sciences, DermaTech, and SciBase Inc. Grichnik is also a major shareholder in DigitalDerm Inc. No other disclosures are reported.
Funding/Support: This study was supported in part by the Frankel Family Division of Melanocytic Tumors, Department of Dermatology and Cutaneous Surgery, the Anna Fund Melanoma Program at Sylvester Comprehensive Cancer Center, University of Miami. The research at the Melanoma Unit in Barcelona, Spain, is partially funded by grants from Fondo de Investigaciones Sanitarias PI 09/01393 and PI 12/00840; by the CIBER de Enfermedades Raras of the Instituto de Salud Carlos III; grant AGAUR 2009 SGR 1337 of the Catalan Government, Spain; by the European Commission under the Sixth Framework Programme, contract No. LSHC-CT-2006-018702 (GenoMEL).
Role of the Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We are indebted to the Anna Fund Melanoma Program at Sylvester Comprehensive Cancer Center, the Frankel Family Division of Melanocytic tumors, Department of Dermatology and Cutaneous Surgery, Department of Dermatology, and our many other benefactors, especially William Rubin and his family and friends. They did not receive compensation for their assistance.